InSysBio announces its participation in the upcoming webinar on CYTOCON organized by ASCPT entitled "CYTOCON: The Manually Curated Database of Human In Vivo Cell and Molecule Concentrations" on November 28, 2023, 9am PT / 12pm ET. This webinar aims to demonstrate key features and application of CYTOCON Database.
CYTOCON DB is a manually curated online database developed by InSysBio for analysis of cell/molecule concentrations measured in different tissues of healthy subjects and patients suffering from various pathologies. It allows collecting, processing and visualizing publicly available data on immune cells and cytokine baseline concentrations in humans. An important feature of CYTOCON is that most values found in papers are converted from a huge variety of original units to unified units: “pM” for cytokine and “kcell/L” for cell concentration. These features of the database can help researchers facilitate the creation and calibration of quantitative systems pharmacology (QSP) models.
Panelists: Vladislav Leonov, PhD, Oleg Demin, PhD, Elita Gerasimuk, and Ekaterina Mogilevskaya, PhD, CYTOCON DB Development Team
You can learn more and register here.
Join the webinar!
About InSysBio
InSysBio is a group of Quantitative Systems Pharmacology (QSP) companies located in Edinburgh, UK (INSYSBIO UK LIMITED), Limassol, Cyprus (INSYSBIO CY Ltd) and Moscow, Russia (INSYSBIO LLC). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry. For more information about InSysBio, its solutions and services, visit www.insysbio.com
| ← | September 2017 | → | ||||
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
|
1
|
2
|
3
| ||||
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
|
11
|
12
|
13
|
14
|
15
|
16
|
17
|
|
18
|
19
|
20
|
21
|
22
|
23
|
24
|
|
25
|
26
|
27
|
28
1.
28 Sep 2017 19:27
Computer model showed an optimal anti-amyloid treatment
Moscow, Russia, September 28, 2017. One must activate amyloid degradation as soon as possible to prevent the appearance of the protein plaques in brain under Alzheimer’s conditions. This conclusion was reached by scientists from the biotechnology company InSysBio, who created the first computer model of the disease. The final part of the work has been recently published in CPT: Pharmacometrics & Systems Pharmacology.
|
29
|
30
| |
Thank you for your message! We will get back to you shortly.
